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Background: Tubal and uterine cavity diseases commonly compromise female fertility. At the present time,
hysteroscopy, laparoscopy with chromopertubation and RX-Hysterosalpingography (RX-HSG) are widely accepted
screening procedures enabling the effective assessment of both tubal patency and uterine cavity. Nevertheless,
consistent evidence supports the reliability of Hysterosalpingocontrast sonography (HyCoSy) in uterine cavity and
tubal patency investigation, as a part of the standard infertility work-up. This prospective study was aimed at
evaluating the tolerability of the technique as well as the incidence of related side effects and complications in a
large series of infertile patients.
Methods: Pain perception of 632 infertile women was measured by means of an 11-point numeric rating scale.
Side effects and late complications were also recorded.
Results: The mean numeric rating scale was 2.15 ± 2.0 SD. Most of the patients (374/632, 59.17%) rated HyCoSy as a
non-painful procedure, whereas 24.36% (154/632) women reported mild pelvic pain and 9.96% (63/632) classified
the discomfort as “moderate”. Only 6.48% (41/632) of the patient population experienced severe pelvic pain. Fifteen
(2.37%) patients required drug administration for pain relief. Twenty-six patients (4.11%) showed mild vaso-vagal
reactions that resolved without atropine administration. No severe vaso-vagal reactions or late complications were
observed.
Conclusions: HyCoSy is a well-tolerated examination and the associated vagal effects are unusual and generally
mild. Consequently, we support its introduction as a first-line procedure for tubal patency and uterine cavity
investigation in infertile women.
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The etiology and pathophysiology of infertility are unex-
plained in some couples, but one-third of infertility cases
are related to female factor. Tubal and uterine cavity dis-
eases commonly compromise female fertility (14% of
couples who require specialist treatment) [1]. In particu-
lar, uterine anomalies or structural abnormalities of the
fallopian tubes are diagnosed in 3% and 16% infertile
women, respectively [2]. For this reason, tubal and* Correspondence: roberto.marci@unife.it
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reproduction in any medium, provided the oruterine examination plays a major role in the evaluation
of the infertile couples and it is mandatory before
assisted reproductive techniques (ART) such as intra-
uterine insemination or in vitro fertilization, is started
[3]. At the present time, hysteroscopy [4,5], laparoscopy
with chromoperturbation and Rx-Hysterosalpingography
(RX-HSG) [6] are widely accepted procedures for the as-
sessment of tubal patency and uterine cavity. However,
these techniques show several limitations including: long
waiting lists in some hospitals, invasiveness (or minimal
invasiveness in the case of office hysteroscopy), painful-
ness and possible surgical and anesthesiologic risks [7].
In addition, RX-HSG is associated to exposure totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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iodinated contrast agent into the uterine cavity, possibly
resulting in atopic phenomena [8]. In the last 10 years,
Hysterosalpingocontrast sonography (HyCoSy) has been
introduced in clinical practice as an effective tool for
tubal patency and uterine cavity evaluation (Figures 1, 2
and 3). This investigation is considered safe, well toler-
ated, rapid, easy to perform and inexpensive [9,10].
HyCoSy is a transvaginal sonography in which a galact-
ose solution containing galactose microbubbles or an in-
expensive mixture of air and saline solution is injected
into the uterine cavity using a cervical catheter. Several
studies [6,9-19] have shown that HyCoSy displays high
specificity and sensitivity in tubal patency and uterine
cavity assessment. On the contrary, only limited evi-
dence is available on both the tolerability and the real in-
cidence of side effects and complications related to this
procedure. This prospective study was aimed at evaluat-
ing these parameters in a large series of infertile patients
undergoing HyCoSy for tubal patency and the uterine
cavity assessment.
Methods
Six hundred thirty-two infertile women, who referred
to our clinic between January 2008 and November
2012, were consecutively enrolled. Patients underwent
HyCoSy at the Andrology and Pathophysiology of
Reproduction Unit of S. Maria Goretti Hospital in
Latina. This work has been carried out in accordance
with The Code of Ethics of the World Medical Associ-
ation (Declaration of Helsinki) for experiments involv-
ing humans. Approval from the institution’s ethics
committee has been obtained before starting the study.
The aim of the examination as well as the possible sideFigure 1 HyCoSy: saline contrast medium expanding a morphologicaeffects and complications associated to the procedure
were explained to the patients and informed consent
was provided in each case before starting the proced-
ure. The clinical data of the study group are summa-
rized in Table 1. Exclusion criteria were a history of
infertility lasting less than one year, abnormal bleeding,
active pelvic infections and uterine malignancies. We
performed pelvic examination, Pap smearing test and
transvaginal ultrasound before HyCoSy. Vaginal and
cervical swabs as well as blood samples for hormonal
profile and serologic markers were also taken. Women
did not receive any pain medication or antibiotic treat-
ment before undergoing the procedure. The patients
were examined in the lithotomic position, during the
first phase of the menstrual cycle (day 9–11 of men-
strual cycle). Patients were asked to use contraceptives
or avoid sexual intercourse from the last menstrual
period until the day of the exam. A preliminary
transvaginal ultrasound was performed by two skilled
operators with a 7 MHz probe (Logiq 5 Expert GE, GE
Healthcare, United Kingdom) in order to exclude
any uterine or adnexal pathology and to localize the
ovaries and the interstitial part of the salpinges before
the injection of the ultrasound contrast medium. The
vulva and the cervix were previously disinfected with
chlorhexidine. A 5 F stylet catheter (CooperSurgical,
Germany) was placed into the cervical os under direct
visualization and the balloon was filled with 1–1.5 ml
of saline solution to fix the catheter and prevent saline
backflow. Then, saline solution (0.9% sodium chloride)
was slowly injected. The uterine cavity was evaluated
on transverse and longitudinal images. The operator
subsequently injected into the catheter a total volume
of 10 to 20 mL saline solution alternated to littlelly normal uterine cavity.
Figure 2 HyCoSy: direct visualization of bilateral tubal patency. (Black arrow: right tube; white arrow: left tube).
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would facilitate checking the patency of the fallopian
tubes. The patency of a tube was determined by the
passage of air bubbles through the tube and/or the
presence of liquid and air in the abdominal cavity near
the ovarian fossas. At the end of the procedure, the pa-
tients were monitored for about 15 minutes in supine
position in order to prevent the onset of vasovagal re-
actions or scapular pain, due to the irritation of the
phrenic nerve. After the execution of the HyCoSy, all
participants were asked about the pain (type, location,
duration, irradiation) they experienced. In order to
quantify pain perception during the procedure we used
an 11-point (0 to 10) numerical rating scale, on which
0 corresponded to no pain at all and 10 indicatedFigure 3 HyCoSy: the periuterine fluid collection (white arrow) is an isevere pain. The patients were familiarized with the
scale before the procedure was performed. In accord-
ance to Savelli et al. [20], pelvic pain was classified as
“absent”, “mild”, “moderate” and “severe” when rated as
0, 1 to 4, 5 to 7 and 8 to 10, respectively.
Results
The mean overall numeric rating scale was 2.15 ± 2.0
SD. The duration of the procedure, from the insertion to
the extraction of the catheter, ranged from 10 to 20
minutes. The majority of patients (374/632; 59.17%)
considered HyCoSy a non-painful procedure, whereas
24.36% (154/632) reported mild pelvic pain and 9.96%
(63/632) classified the discomfort as “moderate”. Only
6.48% (41/632) of the population experienced severendirect sign of tubal patency.
Table 1 Clinical features of the patients who underwent
HyCoSy
N (%)
N. of patients 632
Mean age (years) 33.2 ± 5.4 SD
(range 22–44)
Mean infertility duration (months) 60.4 ± 31.2 SD
(range 24–96)
Primary infertility 452/632 (71.5%)
Secondary infertility 180/632 (28.5%)
Associated pelvic diseases 191/632 (30.2%)
• Myomas • 95/632 (15%)
• Pelvic endometriosis • 54/632 (8.5%)
• Uterine congenital malformations • 37/632 (5.8%)
• Endometrial polyps • 5/632 (0.8%)
Tubal patency:
• Monolateral 503/632 (79.5%)
• Bilateral 53/632 (8.3%)
• Bilateral occlusion 76/632 (12%)
Marci et al. BMC Medical Imaging 2013, 13:28 Page 4 of 7
http://www.biomedcentral.com/1471-2342/13/28pelvic pain. After HyCoSy, 15 (2.37%) patients required
drug administration for pain relief. Twenty-six patients
(4.11%) showed mild vaso-vagal reactions (pallor, nausea,
sudation, hypotension, bradycardia) that resolved without
atropine administration. No severe vaso-vagal reactions
(vomiting, confusion, syncope) and late complicationsFigure 4 Flowchart representing the distribution of women who repe
standard deviation).(haemorrhage, pelvic inflammatory disease (PID), fever)
were reported. We diagnosed bilateral tubal patency in
79.5% (503/632) women, unilateral patency in 8.3% (53/
632) and bilateral tubal occlusion in 12.02% (76/632). In
56/632 (8.8%) patients HyCoSy was not conclusive and
the exam was repeated during the subsequent menstrual
cycle. Women who underwent examination for the second
time considered HyCoSy less painful than the first time
(mean overall numeric rating scale 2.9 vs 6.4) (Figure 4).
The second HyCoSy revealed bilateral tubal patency in
62.5% (35/56) cases and monolateral tubal patency in
21.4% (12/56), whilst diagnostic laparoscopy or RX-HSG
were needed to set a definitive diagnosis in the remaining
16% (9/56) cases. In 191/632 (30%) cases we demonstrated
an associated pelvic disease. The clinical features of the
patient population as well as the main results of the study
are summarized in Table 1 and Table 2.
Discussion
According to several studies, HyCoSy shows high overall
accuracy in the evaluation of both tubal patency and
uterine cavity morphology [6-19]. Furthermore, HyCoSy
avoids both exposure to ionizing radiation and injection
of iodinated contrast medium that could potentially re-
sult toxic. In addition, HyCoSy is inexpensive, fast and
devoid of surgical and anestesthesiologic risks, as op-
posed to laparoscopy with chromopertubation and hys-
teroscopy [7,8]. As other diagnostic methods, HyCoSy
does not always provide exhaustive information aboutated HyCoSy twice (MNRS, mean numeric rating scale; SD,
Table 2 Pain perception, side effects and complications
N (%)
Mean numeric rating scale 2.15 ± 2.0 SD
Pain perception:
• Absent 374/632 (59.17%)
• Mild 154/632 (24.36%)
• Moderate 63/632 (9.96%)
• Severe 41/632 (6.49%)
Painkiller required 15/632 (2.37%)
Mild vaso-vagal reactions (pallor, nausea,
sudation, hypotension, bradycardia)
26/632 (4.11%)
Severe vaso-vagal reactions (vomiting,
confusion, syncope)
0/632 (0%)
Complications (haemorrhage, PID, fever) 0/632 (0%)
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could display misleading images in case of distal tubal
obstruction or complicated pelvic diseases (i.e. PID,
endometriosis, previous appendicitis, abdomino-pelvic
inflammation) [15]. In such doubtful clinical conditions,
laparoscopy with chromoperturbation and hysteroscopy
should still be considered the “gold standard” for tubal
and uterine cavity assessment, respectively.
Our data prove that HyCoSy is a well-tolerated exam-
ination and it is associated to a low incidence of related
complications and side-effects. The pain experienced by
the patients is usually mild and comparable to the
cramping pain felt during a normal menstrual cycle.
Similar findings are reported by Savelli et al. in a pro-
spective study [20]. The Authors evaluated pain percep-
tion by means of an 11-point numeric rating scale in
669 infertile women undergoing HyCoSy. The mean nu-
meric rating scale was 2.7 ± 2.5, only 2% of patients re-
quired a painkiller for pain relief and mild or severe
vasovagal reactions were observed in 4.1% and 0.8%
cases, respectively. Our data concerning pain experienceFigure 5 Evaluation of pain perception in our series and data reporteduring HyCoSy are compared to those provided by
Savelli et al. in Figure 5. In both studies only few pa-
tients reported moderate/severe pain. The only differ-
ence concerns the number of patients who felt no pain
at all or mild discomfort. However, we observed that
several women were frequently unable to distinguish
clearly whether the sensation experienced during the
examination, and in particular after the inflation of the
balloon into the cervical canal, was slightly painful or
just a nuisance comparable to the insertion of the vagi-
nal speculum. As a result, we believe that the findings of
the two studies are similar.
In another recent study Graziano et al. evaluated effi-
cacy, compliance and cost effectiveness of HyCoSy, hys-
teroscopy, and RX-HSG for uterine cavity evaluation
and tubal patency determination [21]. HyCoSy showed
high sensitivity, specificity, positive predictive values
(PPV) and negative predictive values (NPV) and did not
display any significant difference when compared to hys-
teroscopy. Additionally, HyCoSy proved to be as accur-
ate as RX-HSG in detecting a monolateral or bilateral
tubal obstruction. Finally HyCoSy was associated to
milder pain perception and lower costs when compared
to RX-HSG and hysteroscopy. In particular, the Authors
assessed pain by means of an 8-point (0 to 7) numerical
rating scale on which 0 corresponded to no pain at all
and 7 indicated severe pain. Pelvic pain was classified as
“absent”, “mild”, “moderate” and “severe” when rated as
0–1, 2–3, 4–5 and 6–7, respectively. An “absent-mild”
discomfort was reported in 80.84% women undergoing
HyCoSy, in 52.9% women undergoing hysteroscopy and
in 9.1% patients undergoing RX-HSG. Ayida et al. com-
pared HyCoSy to conventional RX-HSG as to the toler-
ability of the procedure [8]. Sixty-six subfertile women
underwent one of the two screening procedures, all
performed by the same operator. No significant differ-
ence in reported procedure time, amount of contrast
medium used, patient tolerability or adverse effects wasd by Savelli et al., 2009.
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perience of 121 infertile women who underwent both
HyCoSy and RX-HSG was analysed [10]. Pain perception
was measured using a self-assessment questionnaire. On
the basis of the results obtained, HyCoSy was suggested
to be a well-tolerated diagnostic procedure, associated
with few or mild vagal effects. During HyCoSy pain was
rated as slightly higher than during RX-HSG. The correl-
ation between pain perception and other independent
variables pertaining to the HyCoSy procedure (i.e. a diffi-
cult catheter passage, amount of contrast medium
injected, unilateral or bilateral tubal blockage, presence
of IgG antibodies to Chlamydia, menstrual cycle phase)
was also investigated in the afore-mentioned study.
The only strong association found concerned the volume
of injected contrast medium. The higher volume of con-
trast medium injected during HyCoSy seems to explain
the significantly higher pain level reported.
Pain perception during HyCoSy could be due to uterine
distension after saline solution infusion. The mechanical
distension of the uterine walls could cause the release of
local prostaglandins, resulting in uterine cramps [22]. Al-
though convincing, this hypothesis has been disconfirmed
by a recent study. In fact it was demonstrated that a pre-
ventive administration of antispasmodic drug such as
hyoscine-N-butylbromide, a muscarinic receptor antagon-
ist with anticholinergic effects, does not decrease pain dur-
ing HyCoSy by affecting uterine contractions [23].
In addition, HyCoSy could also play a therapeutic role
in subfertile women. In our infertility centre we noticed
that spontaneous pregnancies often occurred in patients
who underwent HyCoSy in the previous 3–6 months
[24]. Lindborg et al. [25], recently suggested a valid ex-
planation for this phenomenon: the passage of the fluid
through a partially occluded tube (minor adhesions,
mucus plugs) could remove minor adhesions or buildup
material caused by inflammatory processes and hence
restore tubal patency.
Conclusions
HyCoSy is a well-tolerated procedure and the associated
vagal effects are unusual and generally mild. It is a safe,
efficient and non-invasive diagnostic examination. Fur-
thermore, it provides useful information for the manage-
ment of infertile couples. Therefore we support its use
as a first-line procedure for the evaluation of both the
uterine cavity and the tubal patency in infertile women.
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